CXCR3-Expressing T Cells in Infections and Autoimmunity
The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting t...
Saved in:
Published in | Frontiers in bioscience (Landmark. Print) Vol. 29; no. 8; p. 301 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Singapore
IMR Press
22.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3
Treg cells, and Tc1 CD8
T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4
and CD8
T cells that upregulate inflammation, and also for recruitment of CXCR3
T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases. |
---|---|
AbstractList | The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3+ Treg cells, and Tc1 CD8+ T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4+ and CD8+ T cells that upregulate inflammation, and also for recruitment of CXCR3+ T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases. The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3 Treg cells, and Tc1 CD8 T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4 and CD8 T cells that upregulate inflammation, and also for recruitment of CXCR3 T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases. The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3+ Treg cells, and Tc1 CD8+ T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4+ and CD8+ T cells that upregulate inflammation, and also for recruitment of CXCR3+ T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases.The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3+ Treg cells, and Tc1 CD8+ T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4+ and CD8+ T cells that upregulate inflammation, and also for recruitment of CXCR3+ T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases. |
Author | Isakov, Dmitry Rubinstein, Artem Arsentieva, Natalia Totolian, Areg A Kudryavtsev, Igor Korobova, Zoia R |
Author_xml | – sequence: 1 givenname: Artem surname: Rubinstein fullname: Rubinstein, Artem organization: Department of Immunology, Institute of Experimental Medicine, 197376 Saint Petersburg, Russia – sequence: 2 givenname: Igor surname: Kudryavtsev fullname: Kudryavtsev, Igor organization: Department of Immunology, Institute of Experimental Medicine, 197376 Saint Petersburg, Russia – sequence: 3 givenname: Natalia surname: Arsentieva fullname: Arsentieva, Natalia organization: Laboratory of Immunology, Saint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia – sequence: 4 givenname: Zoia R surname: Korobova fullname: Korobova, Zoia R organization: Laboratory of Immunology, Saint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia – sequence: 5 givenname: Dmitry surname: Isakov fullname: Isakov, Dmitry organization: Department of Immunology, Medical Faculty, First Saint Petersburg State I. Pavlov Medical University, 197022 Saint Petersburg, Russia – sequence: 6 givenname: Areg A surname: Totolian fullname: Totolian, Areg A organization: Laboratory of Immunology, Saint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39206903$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkEtLw0AURgepaK0u3UqWblLn1XksJVQtCIIouBsm85AJyUzNJGD_vaG1urofl8O53O8CzGKKDoBrBJcEQUHumqWvWyynCNEJmGPORMmYFLNj5hCdg6ucGwghlgjJlTgD50RiyCQkc8Crj-qVlOvvbe9yDvGzeCsq17a5CLHYRO_MEFLMhY62uB-HFLpujGHYXYJTr9vsrn7nArw_rN-qp_L55XFT3T-XBgs6lMxT4SUhzjpjVwxJiT0jXqw8qrFGtbOQ1lwIYo2hmBpGpGHMaWgJZ8xqsgCbg9cm3ahtHzrd71TSQe0Xqf9Uuh-CaZ3iWGtHnbfcEmq4kRJxL5iBpvacUTu5bg-ubZ--RpcH1YVspmd1dGnMikApueSUwwktD6jpU86983-nEVT76lWj_quf-Jtf9Vh3zv7Rx6LJDzkTf6Q |
ContentType | Journal Article |
Copyright | 2024 The Author(s). Published by IMR Press. |
Copyright_xml | – notice: 2024 The Author(s). Published by IMR Press. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 DOA |
DOI | 10.31083/j.fbl2908301 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2768-6698 |
ExternalDocumentID | oai_doaj_org_article_72aae4efd7d34c7c9917f86c0cbf764d 10_31083_j_fbl2908301 39206903 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: Saint Petersburg Pasteur Institute via the State Task grantid: 121030200299-3 – fundername: Institute of Experimental Medicine via the State Task grantid: 075-01135-22-00 |
GroupedDBID | 3IV 53G AAFWJ AFPKN ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF ECM EIF GROUPED_DOAJ NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c284t-6f48f933edecd561992f63f85f1b2a1bed04b7883dcc424c639c66ea0d3766da3 |
IEDL.DBID | DOA |
ISSN | 2768-6701 2768-6698 |
IngestDate | Tue Oct 22 15:16:30 EDT 2024 Sat Oct 26 04:12:02 EDT 2024 Wed Sep 04 12:46:52 EDT 2024 Sat Nov 02 12:25:57 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | COVID-19 infection Tc1 Th1 cells Th17.1 cells autoimmunity CXCR3 chemokines CXCR3 Treg CXCR3 receptor follicular Th cell subsets |
Language | English |
License | 2024 The Author(s). Published by IMR Press. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c284t-6f48f933edecd561992f63f85f1b2a1bed04b7883dcc424c639c66ea0d3766da3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://doaj.org/article/72aae4efd7d34c7c9917f86c0cbf764d |
PMID | 39206903 |
PQID | 3099797470 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_72aae4efd7d34c7c9917f86c0cbf764d proquest_miscellaneous_3099797470 crossref_primary_10_31083_j_fbl2908301 pubmed_primary_39206903 |
PublicationCentury | 2000 |
PublicationDate | 2024-08-22 |
PublicationDateYYYYMMDD | 2024-08-22 |
PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-22 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore |
PublicationTitle | Frontiers in bioscience (Landmark. Print) |
PublicationTitleAlternate | Front Biosci (Landmark Ed) |
PublicationYear | 2024 |
Publisher | IMR Press |
Publisher_xml | – name: IMR Press |
SSID | ssj0002911958 |
Score | 2.3142297 |
SecondaryResourceType | review_article |
Snippet | The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both... |
SourceID | doaj proquest crossref pubmed |
SourceType | Open Website Aggregation Database Index Database |
StartPage | 301 |
SubjectTerms | Animals Autoimmune Diseases - immunology Autoimmune Diseases - metabolism autoimmunity Autoimmunity - immunology covid-19 cxcr3 chemokines cxcr3 receptor cxcr3+ treg follicular th cell subsets Humans infection Infections - immunology Inflammation - immunology Inflammation - metabolism Receptors, CXCR3 - immunology Receptors, CXCR3 - metabolism T-Lymphocytes - immunology T-Lymphocytes - metabolism tc1 th1 cells th17.1 cells |
Title | CXCR3-Expressing T Cells in Infections and Autoimmunity |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39206903 https://www.proquest.com/docview/3099797470 https://doaj.org/article/72aae4efd7d34c7c9917f86c0cbf764d |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA4iCF7Et_XFCuItNq9NmmMtFhX0IAq9LXlKpWzFbsH-eye7W_UiXrwtYWHDN9mZb5LJNwidQ8iwNmiJKQ0EC8Ei1oJHbGgQJLpcxJhOdO8f5M2zuBvlox-tvlJNWCMP3ADXVcyYIEL0ynPhlAM-o2JPOuJsVFL42vsS_SOZSj6Y6SRlVrejAz6NpSK0EdgENtPj3dfLaCdMw2PbDGYZkGrd_t_JZh10hptoo2WLWb-Z5RZaCeU2Wmv6Ry52kBqMBo8cX3801azlS_aUDcJkMsvGZXbbllmVs8yUPuvPq-m4vgxSLXbR8_D6aXCD204I2EH4qLCMohc158EH54HxaM2i5LGXR2qZoTZ4Iiwks9w7J5hwQDuclMEQD_5DesP30Go5LcMBynLi4Cc1zsTARaS5zRW1wMI0YCaNoh10sYSjeGsELwpIFGrcIFP4xq2DrhJYXy8lnep6AKxXtNYr_rJeB50toS5gXafDClOG6XxW8HSlNyU7pIP2Gxt8fQo4XRJY5of_MYUjtM6AqKR9YsaO0Wr1Pg8nQDQqe1qvqU9Zec4j |
link.rule.ids | 315,783,787,867,2109,27936,27937 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CXCR3-Expressing+T+Cells+in+Infections+and+Autoimmunity&rft.jtitle=Frontiers+in+bioscience+%28Landmark.+Print%29&rft.au=Artem+Rubinstein&rft.au=Igor+Kudryavtsev&rft.au=Natalia+Arsentieva&rft.au=Zoia+R.+Korobova&rft.date=2024-08-22&rft.pub=IMR+Press&rft.issn=2768-6701&rft.volume=29&rft.issue=8&rft.spage=301&rft_id=info:doi/10.31083%2Fj.fbl2908301&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_72aae4efd7d34c7c9917f86c0cbf764d |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2768-6701&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2768-6701&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2768-6701&client=summon |